Sugi Predict

Sugi Predict / Compounds / SCHEMBL7579915

SCHEMBL7579915

SCHEMBL7579915

COC(=O)[O-].C[P+](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.44
▸ TSHR P16473 2/20 0.43
▸ MAPT P10636 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KCNN4 O15554 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MME P08473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL11217064 0.87 CA2 (0.42) TSHRMAPTGAA
Bicarbonate SCHEMBL8437546 0.87 CA2 (0.42) TSHRMAPTGAA
Acetic Acid SCHEMBL9603211 0.85 CA2 (0.41) TSHRMAPTHSD17B10GAA
Acetic Acid SCHEMBL7872955 0.85 CA2 (0.41) TSHRMAPTHSD17B10GAA
Acetic Acid SCHEMBL9603209 0.83 CA2 (0.39) TSHRMAPTHSD17B10GAA
Benzoic Acid SCHEMBL7874749 0.79 CA2 (0.64) TSHRMAPT
Succinic Acid SCHEMBL6061689 0.79 HDAC3 (0.46) TSHRMAPK1
Propionic Acid SCHEMBL11169478 0.79 CES2 (0.45) KMT2ATSHRMAPTL3MBTL1
Iodide SCHEMBL10484519 0.77 TSHR (0.62) KMT2ATSHRMAPTL3MBTL1HPGD
SCHEMBL7237367 0.77 HIF1A (0.41) TSHRL3MBTL1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109730-A1 Process For The Preparation Of (3Beta,24S)-25,25,25-Trifluoro-3-Methyl-26,27-Dinorergost-5-ene-3,24-Diol IND CHIMICA SRL (IT) 2026-04-23 — — US claimed
US-20260109730-A1 Process For The Preparation Of (3Beta,24S)-25,25,25-Trifluoro-3-Methyl-26,27-Dinorergost-5-ene-3,24-Diol IND CHIMICA SRL (IT) 2026-04-23 — — US disclosed
US-11541120-B2 Phosphonium-based ionic drug conjugates ANTHOS PARTNERS, LP (US) 2023-01-03 — — US disclosed
US-20200353087-A1 PHOSPHONIUM-BASED IONIC DRUG CONJUGATES ANTHOS PARTNERS, LP 2020-11-12 — — US disclosed
WO-2019113210-A1 PHOSPHONIUM-BASED IONIC DRUG CONJUGATES ANTHOS PARTNERS, LP (US) 2019-06-13 — — WO disclosed
EP-0999206-B1 Process for producing alpha cyano acetic acid esters BASF AG (DE) 2002-09-18 — — EP disclosed
US-6130347-A REACTING MONOCHLOROACETIC ESTER WITH HYDROGEN CYANIDE IN BASE PRESENCE; CYANATION BASF AKTIENGESELLSCHAFT (DE) 2000-10-10 — — US disclosed
EP-0999206-A1 Process for producing alpha cyano acetic acid esters BASF AKTIENGESELLSCHAFT (DE) 2000-05-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200353087-A1 PHOSPHONIUM-BASED IONIC DRUG CONJUGATES SLC8B1, PHOSPHO1, PBDC1 KMT2A 4337/4885TSHR 4335/4885MAPT 790/4885
US-20260109730-A1 Process For The Preparation Of (3Beta,24S)-25,25,25-Trifluoro-3-Methyl-26,27-Dinorergost-5-ene-3,24-Diol HSD17B7, CYP11B1, CYP11B2 KMT2A 1986/4885TSHR 1795/4885MAPT 358/4885
US-11541120-B2 Phosphonium-based ionic drug conjugates SLC8B1, PHOSPHO1, PBDC1 KMT2A 4337/4885TSHR 4335/4885MAPT 790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.